Venture Life Group PLC
LSE:VLG

Watchlist Manager
Venture Life Group PLC Logo
Venture Life Group PLC
LSE:VLG
Watchlist
Price: 62 GBX 0.81%
Market Cap: 79.3m GBX

Venture Life Group PLC
Investor Relations

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

Show more
Loading
VLG
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Oct 1, 2025
AI Summary
Q2 2025

Revenue Growth: Group revenue rose 43% to GBP 15.4 million, with 12.5% organic growth, driven by both UK consumer brands and international markets.

Health & Her Acquisition: The Health & Her business contributed GBP 4 million in the first half, boosting reported growth and improving margins due to higher product profitability.

Margin Expansion: Gross margin increased to 43.1%, up from 41.2% last year, aided by the mix shift from higher-margin brands.

Marketing Investment: Marketing spend rose to 10.5% of group sales (14.5% on supported brands), targeting brand awareness and long-term revenue acceleration.

Cash Position & Firepower: Following the CDMO divestment, net cash was GBP 34 million at September end, with up to GBP 85 million available for acquisitions.

Brand Performance: Strong growth in women's health (Balance Activ up 24%) and Health & Her (up 35%), but energy management brands declined due to a temporary NHS ordering issue.

Strategic Refocus: The company completed its shift to a capital-light, brand-led model, divesting manufacturing and non-core brands to focus on high-margin categories.

Outlook: Management is confident in continued organic growth, margin improvement, and upcoming acquisitions, with a strong emphasis on innovation, digital, and international expansion.

Key Financials
Revenue
GBP 15.4 million
Organic Revenue Growth
12.5%
Gross Profit
GBP 6.6 million
Gross Margin
43.1%
Adjusted EBITDA
GBP 1.8 million
Adjusted EBITDA Margin
11.6%
Free Cash Flow
GBP 1.5 million
Net Cash
GBP 34 million
Marketing Spend (as % of Sales)
10.5%
Marketing Spend on Supported Brands (as % of Sales)
14.5%
Health & Her Revenue Growth
38%
Balance Activ Revenue Growth
24%
Earol UK Revenue Growth
15%
Earol International Revenue
GBP 3 million
Energy Management Division Revenue Growth
-11%
Oncology Support Revenue Growth
200%
Interest Rate Earned on Cash
just over 4%
Earnings Call Recording
Other Earnings Calls
2025

Management

Mr. Jeremy Anthony Philip Randall ACA
Co-Founder, CEO & Executive Director
No Bio Available
Mr. Daniel James Wells
CFO & Director
No Bio Available
Mr. Lodovico Gianluca Braguti
Chief Manufacturing Officer & Executive Director
No Bio Available
Ben Colman
Director of Corporate Development
No Bio Available
Mr. Domenico Barbaro
Head of Procurement
No Bio Available
Mr. Ennio Schiro
Head of ESG Strategy
No Bio Available

Contacts

Address
BERKSHIRE
Bracknell
Unit 12, The Courtyard, Eastern Road
Contacts
+441344578004.0
www.venture-life.com